These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3749448)

  • 1. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom.
    Bateman DN; Rawlins MD; Simpson JM
    Q J Med; 1986 Jun; 59(230):549-56. PubMed ID: 3749448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal reactions to metoclopramide and prochlorperazine.
    Bateman DN; Darling WM; Boys R; Rawlins MD
    Q J Med; 1989 Apr; 71(264):307-11. PubMed ID: 2594960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy.
    Factor SA; Matthews MK
    South Med J; 1991 May; 84(5):626-8. PubMed ID: 2035085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compazine complications: a review.
    Baker FM; Cook P
    J Natl Med Assoc; 1981 May; 73(5):409-12. PubMed ID: 7014918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapyramidal reactions with metoclopramide.
    Bateman DN; Rawlins MD; Simpson JM
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):930-2. PubMed ID: 3929968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of adverse reactions to prochlorperazine in the ED.
    Olsen JC; Keng JA; Clark JA
    Am J Emerg Med; 2000 Sep; 18(5):609-11. PubMed ID: 10999579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal side effects of antipsychotic medications.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762
    [No Abstract]   [Full Text] [Related]  

  • 12. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute-onset extrapyramidal syndromes caused by drugs].
    Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G
    Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse neurologic effects of metoclopramide.
    Grimes JD; Hassan MN; Preston DN
    Can Med Assoc J; 1982 Jan; 126(1):23-5. PubMed ID: 7059869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tardive dystonia. A rare neuroleptic-induced disease picture].
    Assion HJ; Heinemann F
    Nervenarzt; 1994 Nov; 65(11):795-7. PubMed ID: 7816158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiemetic-induced extrapyramidal symptoms seen by our palliative care team].
    Nakanuno R; Ito T; Matsunaga A; Kawamoto M
    Masui; 2010 May; 59(5):645-7. PubMed ID: 20486582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.